{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20150302",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "10315",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/204275Orig1s002ltr.pdf",
              "date": "20150303",
              "type": "Letter"
            },
            {
              "id": "19540",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204275s002lbl.pdf",
              "date": "20150305",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "17",
          "submission_status": "AP",
          "submission_status_date": "20190107",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "57129",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204275s017lbl.pdf",
              "date": "20190108",
              "type": "Label"
            },
            {
              "id": "57538",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/204275Orig1s017ltr.pdf",
              "date": "20190213",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "15",
          "submission_status": "AP",
          "submission_status_date": "20171220",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "50842",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/204275s015lbl.pdf",
              "date": "20171222",
              "type": "Label"
            },
            {
              "id": "50879",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/204275Orig1s015ltr.pdf",
              "date": "20171227",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "9",
          "submission_status": "AP",
          "submission_status_date": "20160216",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "40370",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/204275s009lbl.pdf",
              "date": "20160218",
              "type": "Label"
            },
            {
              "id": "32536",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/204275Orig1s009ltr.pdf",
              "date": "20160218",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "11",
          "submission_status": "AP",
          "submission_status_date": "20161031",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "45776",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/204275Orig1s011ltr.pdf",
              "date": "20161102",
              "type": "Letter"
            },
            {
              "id": "45804",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/204275s011lbl.pdf",
              "date": "20161104",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5",
          "submission_status": "AP",
          "submission_status_date": "20150811",
          "review_priority": "STANDARD",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20150430",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "40368",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204275s001lbl.pdf",
              "date": "20150504",
              "type": "Label"
            },
            {
              "id": "32534",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/204275Orig1s001ltr.pdf",
              "date": "20150504",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20130510",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "application_docs": [
            {
              "id": "19539",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204275s000lbl.pdf",
              "date": "20130514",
              "type": "Label"
            },
            {
              "id": "22949",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/204275Orig1s000TOC.html",
              "date": "20130610",
              "type": "Review"
            },
            {
              "id": "32533",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/204275Orig1s000ltr.pdf",
              "date": "20130513",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "22",
          "submission_status": "AP",
          "submission_status_date": "20230512",
          "review_priority": "PRIORITY",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "74241",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/204275Orig1s022ltr.pdf",
              "date": "20230515",
              "type": "Letter"
            },
            {
              "id": "74250",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204275Orig1s022lbl.pdf",
              "date": "20230515",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "12",
          "submission_status": "AP",
          "submission_status_date": "20170515",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "48387",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/204275s012lbl.pdf",
              "date": "20170517",
              "type": "Label"
            },
            {
              "id": "48403",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/204275Orig1s012ltr.pdf",
              "date": "20170517",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "8",
          "submission_status": "AP",
          "submission_status_date": "20151021",
          "review_priority": "STANDARD",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "4",
          "submission_status": "AP",
          "submission_status_date": "20150915",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "40369",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204275s004lbl.pdf",
              "date": "20150923",
              "type": "Label"
            },
            {
              "id": "32535",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/204275Orig1s004ltr.pdf",
              "date": "20150916",
              "type": "Letter"
            }
          ]
        }
      ],
      "application_number": "NDA204275",
      "sponsor_name": "GLAXO GRP LTD",
      "openfda": {
        "application_number": [
          "NDA204275"
        ],
        "brand_name": [
          "BREO ELLIPTA",
          "FLUTICASONE FUROATE AND VILANTEROL"
        ],
        "generic_name": [
          "FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE",
          "FLUTICASONE FUROATE AND VILANTEROL"
        ],
        "manufacturer_name": [
          "GlaxoSmithKline LLC",
          "Prasco Laboratories"
        ],
        "product_ndc": [
          "0173-0859",
          "0173-0916",
          "0173-0882",
          "66993-135",
          "66993-136"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "RESPIRATORY (INHALATION)"
        ],
        "substance_name": [
          "FLUTICASONE FUROATE",
          "VILANTEROL TRIFENATATE"
        ],
        "rxcui": [
          "1424889",
          "1424899",
          "1539891",
          "1539893",
          "1648783",
          "1648785",
          "1648788",
          "1648789",
          "2637473",
          "2637476"
        ],
        "spl_id": [
          "03107b41-0bf9-463a-a6e4-956444373e81",
          "18928e94-a9ff-44a6-a65e-c6f8c21c815c"
        ],
        "spl_set_id": [
          "96428df1-ea05-431a-98d3-1ec2c4b63878",
          "3a761487-c300-451a-8537-3196c00c11b5"
        ],
        "package_ndc": [
          "0173-0916-10",
          "0173-0859-10",
          "0173-0859-14",
          "0173-0859-61",
          "0173-0882-10",
          "0173-0882-14",
          "0173-0882-61",
          "66993-135-97",
          "66993-136-97"
        ],
        "unii": [
          "40AHO2C6DG",
          "JS86977WNV"
        ]
      },
      "products": [
        {
          "product_number": "002",
          "reference_drug": "Yes",
          "brand_name": "BREO ELLIPTA",
          "active_ingredients": [
            {
              "name": "FLUTICASONE FUROATE",
              "strength": "0.2MG/INH"
            },
            {
              "name": "VILANTEROL TRIFENATATE",
              "strength": "EQ 0.025MG BASE/INH"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "POWDER",
          "route": "INHALATION",
          "marketing_status": "Prescription"
        },
        {
          "product_number": "003",
          "reference_drug": "Yes",
          "brand_name": "BREO ELLIPTA",
          "active_ingredients": [
            {
              "name": "FLUTICASONE FUROATE",
              "strength": "0.05MG/INH"
            },
            {
              "name": "VILANTEROL TRIFENATATE",
              "strength": "EQ 0.025MG BASE/INH"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "POWDER",
          "route": "INHALATION",
          "marketing_status": "Prescription"
        },
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "BREO ELLIPTA",
          "active_ingredients": [
            {
              "name": "FLUTICASONE FUROATE",
              "strength": "0.1MG/INH"
            },
            {
              "name": "VILANTEROL TRIFENATATE",
              "strength": "EQ 0.025MG BASE/INH"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "POWDER",
          "route": "INHALATION",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}